PTC Therapeutics to Acquire Censa Pharmaceuticals
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/20/2026
- Nasdaq climbs as chip and AI-linked stocks bounce back
- U.S. economy is "booming," JPMorgan’s Dimon says
- Musk pledges one share of SpaceX to every U.S. child
- Brent crude edges lower, even after Houthi attacks on Saudi infrastructure
- Prepare to buy the dip as U.S. stock selloff nears its end: Morgan Stanley
| PTC THERAPEUTICS (NASDAQ: PTCT) | Delayed: 61.53 +2.29 (3.87%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $59.24 | 52 Week High | $35.40 | |||
| Open | $60.13 | 52 Week Low | $4.03 | |||
| Day High | $61.74 | P/E | 6.55 | |||
| Day Low | $59.35 | EPS | $9.40 | |||
| Volume | 943,992 | |||||
